Streetbeat News

Stock Prices

AAPL

TSLA

Tesla Inc. (TSLA) and Apple Inc. (AAPL) are facing challenges in China due to an economic slowdown and growing competition from local companies like BYD Company Ltd. and Huawei Technologies. Despite these challenges, analyst Dan Ives believes both companies cannot abandon China, a crucial market for their growth. Tesla has seen some positive vehicle sales, while Apple's sales dropped 33% year-on-year in February. Both companies are advised to navigate through these challenges without abandoning the Chinese market.

Portfolio Pulse from Rounak Jain

April 12, 2024 | 2:04 pm

ABBV

Smart money investors are showing a significant interest in AbbVie (NYSE:ABBV) options, with a bearish sentiment prevailing. Benzinga's tracking revealed a mix of bullish and bearish options activities, with a notable lean towards bearish positions (70%). The options activities suggest a targeted price range for ABBV between $70.0 and $180.0. Currently, ABBV's stock is down by -1.54%, trading at $163.42, with an RSI indicating it may be oversold. Analysts from Guggenheim and Barclays have given ABBV buy and overweight ratings, with target prices of $190 and $195, respectively.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 2:04 pm

RENT

Shares of Rent the Runway were halted due to a circuit breaker after surging 37.7% to the upside, indicating a significant increase in stock price.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 2:02 pm

DKS

Analyst ratings for Dick's Sporting Goods (NYSE:DKS) show diverse perspectives, with recent updates indicating a positive shift in sentiment. The average 12-month price target has risen to $217.17, reflecting a 30.32% increase from the previous target. Analysts from firms like Jefferies, Oppenheimer, and UBS have adjusted their ratings and price targets, generally raising their expectations for DKS's stock performance. The company's financial health is strong, with a market capitalization above industry average, a revenue growth rate of 7.77%, and superior net margin, ROE, and ROA compared to industry averages.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 2:01 pm

ZS

Zscaler (NASDAQ:ZS) has significantly outperformed the market with an annualized return of 22.4% over the past 5 years, turning a $1000 investment into $2,715.54. The company now has a market capitalization of $27.28 billion.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 2:00 pm

FN

Over the past 10 years, Fabrinet (NYSE:FN) has delivered an average annual return of 23.46%, outperforming the market by 12.75% on an annualized basis. With a current market capitalization of $6.30 billion, an initial investment of $1000 in FN stock would have grown to $8,379.34 today.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 2:00 pm

SPY

The Michigan Consumer Sentiment Index for April came in at 77.9, below the estimated 79.0 and the previous month's 79.4, indicating a slight decline in consumer confidence.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 2:00 pm

AFCG

IIPR

MSOS

NLCP

REFI

SSIC

Chicago Atlantic Real Estate Finance (NASDAQ:REFI) is highlighted for its growth and resilience in the cannabis sector, with a bullish Overweight rating from Zuanic & Associates. The report compares REFI favorably against AFC Gamma (NASDAQ:AFCG), noting its superior loan portfolio performance and lower non-accruals. REFI's dividend is expected to increase, and its stock has shown an 11% year-on-year growth. The analysis also mentions other significant stocks in the sector, including MSOS (ETF: MSOS), IIPR (NYSE:IIPR), NLCP (OTC:NLCP), and SSIC (NASDAQ:SSIC), each offering unique investment opportunities in the cannabis market.

Portfolio Pulse from Nicolás Jose Rodriguez

April 12, 2024 | 2:00 pm

USO

VGK

Russian oil and products are currently stranded on four tankers due to new Iran-related sanctions, according to Reuters citing LSEG data. This development could impact the global oil supply chain and market dynamics, potentially affecting related stocks and ETFs.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 1:58 pm

RANI

Rani Therapeutics Holdings saw a notable options activity with a sweep of 143 calls for April 19 at a $2.5 strike price near the ask, against an open interest of 765. This activity comes ahead of their estimated earnings report on May 8, after market close, with the reference stock price at $5.12.

Portfolio Pulse from Charles Gross

April 12, 2024 | 1:58 pm